Companies › CGON

CG ONCOLOGY INC (CGON)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001991792 · EDGAR filings · Updated 2026-07-28

CG ONCOLOGY INC (CGON) has reported institutional ownership of 104.4%, with 234 institutional managers holding positions valued at $5.93B per the latest 13F reporting period.

Filings this week (4)

• 2026-07-28 — Notice of proposed sale filed (Form 144)
• 2026-07-27 — SCHEDULE 13G/A filed
• 2026-07-27 — Notice of proposed sale filed (Form 144)
• 2026-07-23 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-15 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CG ONCOLOGY INC has 234 institutional holders and institutional ownership of 104.4%.

Insider activity

Insiders reported 46 transactions (1 buys, 24 sells) across 5 reporting insiders, with a net reported value of $43.6M.

Related companies

MIRUM PHARMACEUTICALS INC (MIRM) · GLAUKOS CORP (GKOS) · ALKERMES PLC (ALKS) · CENTESSA PHARMACEUTICALS PLC (CNTA) · XENON PHARMACEUTICALS INC (XENE) · TELEFLEX INCORPORATED (TFX)